← Back to Search

Narrative Enhancement and Cognitive Therapy for First Episode Psychosis (NECT-YA Trial)

N/A

Recruiting

Research Sponsored by John Jay College of Criminal Justice, City University of New York

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Meets criteria for FEP youth based on the following definition: age 15-24, onset of psychotic symptoms within the last 5 years, and an absence of a primary substance use or mood disorder that could be causing the psychotic symptoms (confirmed by program eligibility)

Speaks English well enough to complete assessments and participate in groups

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 20 minutes

Awards & highlights

NECT-YA Trial Summary

This trial will adapt and test a new therapy for people ages 15-24 with psychosis, to increase treatment engagement and help with self-concept and illness. It will then be tested in a 40-person trial.

Who is the study for?

This trial is for young people aged 15-24 who are experiencing their first episode of psychosis within the last five years, without a primary substance use or mood disorder causing symptoms. Participants should have moderate to high self-stigma and must speak English well enough for assessments and group participation.Check my eligibility

What is being tested?

The study is testing an adapted version of Narrative Enhancement and Cognitive Therapy (NECT) designed for young adults with first episode psychosis, combined with Coordinated Specialty Care (CSC). It compares this combination treatment's effectiveness against CSC alone in a small randomized controlled trial.See study design

What are the potential side effects?

Since NECT-YA involves therapy rather than medication, side effects may include emotional discomfort or distress during sessions. However, physical side effects commonly associated with drug interventions are not expected.

NECT-YA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am aged 15-24, started experiencing psychosis in the last 5 years, and don't primarily use substances or have a mood disorder.

Select...

I can speak English well enough for medical assessments and group participation.

NECT-YA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 20 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~20 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Coping with Symptoms Checklist

Treatment Engagement

Working Alliance Inventory Short Form-Client Version

Secondary outcome measures

Beck Hopelessness Scale

Quality of Life Scale

Rosenberg Self Esteem Scale

Other outcome measures

Internalized Stigma of Mental Illness Scale

Positive and Negative Syndrome Scale

Recovery Style Questionnaire Recovery Style Questionnaire

NECT-YA Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Narrative Enhancement and Cognitive Therapy- Young Adult, Combined with Coordinated Specialty CareExperimental Treatment2 Interventions

NECT is a structured, 20-session group-based treatment called that combines psychoeducation, cognitive restructuring, and elements of narrative psychotherapy. NECT-YA will be modified to meet the needs of people who have experienced an FEP and may have fewer sessions or be provided in individual format or via telehealth for this study. NECT-YA will be offered to participants who are also receiving treatment within Coordinated Specialty Care programs for First Episode Psychosis.

Group II: Coordinated Specialty CareActive Control1 Intervention

Coordinated Specialty Care is an evidence-based treatment for FEP that includes multiple treatment components. The FEP programs in at the recruiting site follow the Coordinated Specialty Care model.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

John Jay College of Criminal Justice, City University of New YorkLead Sponsor

2 Previous Clinical Trials

270 Total Patients Enrolled

Indiana University School of MedicineOTHER

185 Previous Clinical Trials

142,753 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical experiment accept participants aged eighty-five and over?

"This medical study is seeking participants aged 15-24."

Answered by AI

Does my profile match the criteria for joining this research project?

"To be admitted to this research project, those with initial episode psychosis and aged between 15-24 are eligible. A total of 40 individuals will ultimately take part in the trial."

Answered by AI

What is the cap on participants in this trial?

"Affirmative. According to clinicaltrials.gov, the study was initially made available on August 1st 2023 and has since been updated as recently as October 4th 2023; it is currently looking for 40 research participants from a single site."

Answered by AI

Are there any openings in this experiment for new participants?

"Affirmative. Clinicaltrials.gov reveals that recruitment is still taking place for this trial, which was first posted on August 1st 2023 and most recently updated on October 4th 2023. Specifically, 40 participants are needed from a single site location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pilot RCT of Self-stigma Treatment for First Episode Psychosis

2023. "Pilot RCT of Self-stigma Treatment for First Episode Psychosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04889911.